Predicting the recurrence/metastasis of stage II and III breast cancer with lymph node metastasis

Oncology Reports

Volumn 12, Issue 2, 2004, Pages 303-306

  Mukai, Masaya ^a   Sato, Shinkichi ^a   Kimura, Tomomi ^a   Komatsu, Nobukazu ^a   Ninomiya, Hiromi ^a   Nakasaki, Hisao ^a   Ogoshi, Kyouji ^b   Makuuchi, Hiroyasu ^b  

^a TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; High risk group; Isolated tumor cells; Lymph node metastasis; Micro metastasis; Occult neoplastic cells; Recurrence and metastasis

Indexed keywords

KERATIN;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; PATHOLOGY; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; TIME;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 16544392842     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.2.303     Document Type: Article

References (29)

1. Omejc M, Juvan R, Jelenc F and Repse S: Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg 86: 14-19, 2001. (Pubitemid 33594597)
2. Japanese Society for Cancer of the Colon and Rectum: Multi-Institutional Registry of Large Bowel Cancer in Japan. Cases treated in 1994. Vol. 23. Tokyo, 2002.
3. Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Brochhagen H-G, Schneider PM and Holscher AH: Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 123: 463-467, 2003. (Pubitemid 36269431)
4. Hasebe T, Sasaki S, Imoto S and Ochiai A: Significance of nodal metastatic tumor characteristics in nodal metastasis and prognosis of patients with invasive ductal carcinoma of the breast. Cancer Sci 94: 181-187, 2003. (Pubitemid 36575878)
5. Goldhirsch A, Glick JH, Gelber RD and Senn H-J: Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90: 1601-1608, 1998. (Pubitemid 28523434)
6. National Institutes of Health Consensus Development Panel: National Institutes of Health consensus development conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 93: 979-989, 2001.
7. Goldhirsch A, Glick JH, Gelber RD, Coates AS and Senn H-J: Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 19: 3817-3827, 2001. (Pubitemid 32880060)
8. Abrams JS: Adjuvant therapy for breast cancer-results from the USA consensus conference. Breast Cancer 8: 298-304, 2001.
9. Mukai M, Tajima T, Saito Y, Ito I, Nakasaki H, Sato S and Makuuchi H: Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study. Oncol Rep 10: 927-934, 2003.
10. Mukai M, Tajima T, Nakasaki H, Sato S, Ogoshi K and Makuuchi H: Efficacy of postoperative adjuvant oral immunochemotherapy in patients with Dukes' B colorectal cancer. Ann Cancer Res Therap 11: 201-214, 2003. (Pubitemid 39334896)
11. Mukai M, Tajima T, Nakasaki H, Sato S, Ogoshi K and Makuuchi H: Efficacy of postoperative adjuvant oral immunochemotherapy in patients with Dukes' C colorectal cancer. Ann Cancer Res Therap 11: 215-229, 2003. (Pubitemid 39341153)
12. Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer. Oncol Rep 10: 1177-1181, 2003.
13. Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer. Oncol Rep 10: 1165-1169, 2003.
14. Mukai M, Sato S, Nishida T, Komatsu N, Shiba K, Nakasaki H and Makuuchi H: Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer. Oncol Rep 10: 1753-1758, 2003.
15. Mukai M, Sato S, Nakasaki H, Saito Y, Nishiumi N, Iwasaki M, Tokuda Y, Ogoshi K, Inoue H and Makuuchi H: Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal and gastric cancer. Oncol Rep 11: 81-84, 2004.
16. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Nakasaki H and Makuuchi H: Accuracy of criteria for predicting recurrence and metastasis in stage II and III gastric cancer patients with lymph node metastasis. Oncol Rep 12: 63-66, 2004.
17. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma. 1st English edition. Kanehara & Co., Ltd., Tokyo, 1995.
18. Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer. 13th edition. Kanehara & Co., Ltd., Tokyo, 1998.
19. Japanese Society for Cancer of the Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. 6th edition. Kanehara & Co., Ltd., Tokyo, 1998.
20. Nakane PK and Pierce GB: Enzyme-labeled antibodies: preparation and application for localization of antigens. J Histochem Cytochem 14: 929-931, 1966.
21. Nakane PK and Pierce GB: Enzyme-labeled antibody for the light and electron microscopic localization of tissue antigens. J Cell Biol 33: 307-318, 1967.
22. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, MacDonald JS, Catalano PJ and Haller DG: Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21: 2912-2919, 2003. (Pubitemid 46621841)
23. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D and Sargent D: Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93: 583-596, 2001. (Pubitemid 32409626)
24. TNM Classification of Malignant Tumours. 6th edition. John Wiley & Sons, Inc., New York, 2002.
25. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, van de Velde CJH, Hermans J, van Krieken JHJM, Cornelisse CJ and Tollenaar RAEM: Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339: 223-228, 1998. (Pubitemid 28350164)
26. Öberg A, Stenling R, Tavelin B and Lindmark G: Are lymph node micrometastases of any clinical significance in Dukes stages A and B colorectal cancer? Dis Colon Rectum 41: 1244-1249, 1998. (Pubitemid 28477972)
27. Braun S, Rosenberg R, Thorban S and Harbeck N: Implication of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer. Semin Surg Oncol 20: 334-346, 2001. (Pubitemid 33044278)
28. Hawes D, Neville AM and Cote RJ: Detection of occult metastasis in patients with breast cancer. Semin Surg Oncol 20: 312-318, 2001. (Pubitemid 33044275)
29. Osaka Prefectural Department of Public Health and Welfare, Osaka Medical Assosiation, Osaka Medical Center, for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 65 - Cancer Incidence and Medical Care in Osaka in 1999 and the survival in 1995. OPDPHW, 2002. Organization